In the opinion of the specialists of the State Medicines Control Agency of Lithuania, the conditions of parallel import to Lithuania are rather liberal. The greatest difficulties probably arise due to the existing agreements among the pharmaceutical marketing authorization holders and pharmacy networks.

The Agency emphasize that the declared prices of parallel imported medicines are lower, and this ensures a better access to medicines. They also state that parallel imported pharmaceuticals can improve the safety of drug supply.

"Importing pharmaceuticals parallel gives the opportunity to supply pharmaceuticals quicker " - Delija Milašiūtė, the Medicines Control Agency's public relations representative, explains.


From 2015 m. April until 2016 m. May Bristol has shortage of Megace 40 mg/ml susp.(oncology)

For 10 months, Lexano have satisfied the market need 100%.

More information on Verso Zinios